WOONSOCKET, Rhode Island, Jan. 5 -- CVS Health issued the following news release on Jan. 4, 2024: Today CVS Caremark(R), a CVS Health(R) (NYSE: CVS) company, announced the continuation of its efforts to expand adoption of biosimilars. Effective April 1, 2024, Humira(R) will be removed from our major national commercial template formularies and Humira biosimilars will be covered. Humira will continue to be an option for its customers with Choice and Standard Opt Out commercial formularies. Comme more PR

PROVIDENCE, Rhode Island, Jan. 5 -- The Rhode Island Department of Education issued the following news release: Governor Dan McKee, Commissioner Angelica Infante-Green, and the Rhode Island Department of Education (RIDE) highlighted the agency's accomplishments and successes for 2023. Through the launch and the continuation of initiatives and programs, the agency continues efforts to lead and support districts, schools, and communities through a unified, strategic direction; use policy, advocac more PR